Impact of Statin Therapy on Clinical Outcome in Patients With Coronary Spasm
Masanobu Ishii(Kumamoto University), Hisao Ogawa(Jikei University School of Medicine), Hirofumi Soejima(Kumamoto Health Science University), Yuichiro Arima(Kumamoto University), Kenichi Tsujita(British Heart Foundation), Kenji Sakamoto(Kumamoto University), Kunihiko Matsui(Kumamoto University), Koji Sato(Kumamoto University), Daisuke Sueta(Mie University), Tomonori Akasaka, Seiji Hokimoto(Omuta hospital), Sunao Kojima(Kumamoto University), Koichi Kaikita(Kumamoto University), Takashi Miyazaki, Megumi Yamamuro(IRYO Sosei University), Noriaki Tabata(Kumamoto University), Eiichiro Yamamoto(Mie University), Kenshi Yamanaga(Kumamoto University)
Cited by 71
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2015|449